Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00233688 · ClinicalTrials.gov registry record · Phase 3

Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)

A Phase 3 study, sponsored by Cordis US.

Completed
Registry status
Phase 3
Development phase
300
Enrollment target

NCT00233688: Completed Phase 3 study, sponsored by Cordis US.

NCT00233688 is a Phase 3 study that has completed, run by Cordis US. The registered enrollment target is 300 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00233688, a Phase 3 study, has completed, sponsored by Cordis US.

COMPLETED
Registry status
Phase 3
Development phase
300 participants
Enrollment target

Study Summary

The objective of this clinical study is to assess the safety and effectiveness of the Cordis Endovascular Quantum LP™ Stent Graft System.

Interventions

  • PROCEDURE Open surgical repair
  • DEVICE QUANTUM LP™ STENT GRAFT SYSTEM

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2001-11
Est. Completion 2009-04
Phase Phase 3
Cordis US

19 total trials

What the finished NCT00233688 record still lists

NCT00233688 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (61% lower).

The record links to 0 conditions, and to 2 interventions - of which Open surgical repair is the first listed.

NCT00233688 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00233688 about?

NCT00233688 is a clinical study titled "Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)". The objective of this clinical study is to assess the safety and effectiveness of the Cordis Endovascular Quantum LP™ Stent Graft System.

What is the current status of trial NCT00233688?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2001-11. Estimated completion is 2009-04.

What interventions are being tested in trial NCT00233688?

The interventions under investigation include: Open surgical repair (PROCEDURE), QUANTUM LP™ STENT GRAFT SYSTEM (DEVICE).

Who is sponsoring clinical trial NCT00233688?

This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00233688's enrollment target sits among peer trials

300 1122nd of 2000 higher than 840 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00233688, the US trial registry maintained by the National Library of Medicine. NCT00233688 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.